Whenever cells activate a gene, they produce gene specific transcript molecules, which make the function of the gene available to the cell. The measurement of gene activity is a routine activity in medical diagnostics, especially in cancer medicine. Today’s technologies determine the activity of genes by measuring the amount of transcript molecules. …
German researchers have identified four biomarkers that correctly determine malignancy of urinary bladder cancers and contribute to the accurate prediction of patient outcomes. Their results are published in the September issue of The Journal of Molecular Diagnostics. Current prognosticators of bladder cancer, such as tumor grade, stage, size, and number of foci, have limited usefulness for clinicians since they do not accurately reflect clinical outcomes…
That’s according to research presented to the 2013 European Cancer Congress in Amsterdam. The team of scientists is led by an investigator at University of Colorado Cancer Center. An analysis of 20,034 patients in 24 phase III clinical trials showed that the youngest and oldest patients had the highest risk of disease progression and death, compared to middle-aged patients…
It is estimated that around 570,000 people are living with, or after, a diagnosis of breast cancer in the UK, and this number is expected to double by 2030. Breast cancer, therefore, remains a significant challenge. Over 100 specialist breast cancer scientists, clinicians and heath care professionals reviewed a wide range of issues and challenges involved in breast cancer research, prevention and treatment. Through facilitated discussions and consultation, including appraisal from experts and patients, they produced an account outlining ten major gaps and five strategic solutions. …
The benefits of fruit and vegetable consumption are not a new discovery. However, new research confirms their role in reducing mortality…
"Our finding provides a target to prevent these rearrangements, so we could conceivably prevent cancer in some high-risk people," said senior author Edward P. (Paul) Hasty, D.V.M., of the School of Medicine at The University of Texas Health Science Center at San Antonio. …
The risk of litigation has not been given a great deal of attention in primary care, say the authors. But with most healthcare contacts taking place in primary care, it is important to characterise the causes and types of claims arising from these encounters, they add…
"In this new study, we find that giving lunasin orally at 20 mg/kg of body weight reduced the number of metastatic tumors by 94 percent — we went from 18 tumors to only one. And that was done using lunasin alone; no other type of therapy was used," said Elvira de Mejia, a U of I professor of food chemistry and food toxicology. In the first study, injections of lunasin were used in concert with the chemotherapy drug oxaliplatin, yielding impressive results: a sixfold reduction in metastatic tumors to the liver. …
source : http://www.foxnews.com/health/2013/06/28/family-reveals-10-year-old-girl-who-fought-organ-donation-guidelines-had-second/
source : http://www.foxnews.com/health/2013/06/27/heavy-drinkers-have-more-post-surgery-problems/